Literature DB >> 28011910

Induction of H7N9-Cross-Reactive Antibody-Dependent Cellular Cytotoxicity Antibodies by Human Seasonal Influenza A Viruses that are Directed Toward the Nucleoprotein.

Sinthujan Jegaskanda1,2, Mary Dawn T Co3, John Cruz4, Kanta Subbarao1, Francis A Ennis3, Masanori Terajima3.   

Abstract

Antibodies that mediate antibody-dependent cellular cytotoxicity (ADCC) against avian influenza virus subtypes, including H7N9 and H5N1, have been detected in human sera. Using NK cell activation and NK cytotoxicity assays, we compared ADCC-mediating antibodies (ADCC-Abs) in sera collected from healthy infants, children and adults against H7N9 virus-infected cells and recombinant hemagglutinin (HA), neuraminidase (NA), and nucleoprotein (NP) proteins. High titers of ADCC-Abs against H7N9 virus-infected cells were detected in sera from adults and children but not infants. ADCC-Abs titers directed against H7N9 HA or NA proteins. Further analysis showed that ADCC-Abs titers were significantly higher toward H7N9 NP, as compared with H7N9 HA or NA proteins, and correlated strongly with ADCC-Abs titers against H7N9 virus-infected cells. Indeed, ADCC-Abs to NPs of seasonal H1N1 and H3N2 viruses correlated strongly with ADCC-Abs to H7N9 NP, suggesting that seasonal influenza infections and vaccinations may induce these cross-reactive antibodies. Targeting ADCC-Abs to internal proteins may be a potential mechanism of universal vaccine design.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  ADCC; antibody; antibody-dependent cellular cytotoxicity; influenza virus; nucleoprotein

Mesh:

Substances:

Year:  2017        PMID: 28011910      PMCID: PMC5853654          DOI: 10.1093/infdis/jiw629

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  27 in total

1.  Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection.

Authors:  David J DiLillo; Peter Palese; Patrick C Wilson; Jeffrey V Ravetch
Journal:  J Clin Invest       Date:  2016-01-05       Impact factor: 14.808

2.  Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo.

Authors:  David J DiLillo; Gene S Tan; Peter Palese; Jeffrey V Ravetch
Journal:  Nat Med       Date:  2014-01-12       Impact factor: 53.440

3.  Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2.

Authors:  Syed Sohail Ahmed; Wayne Volkmuth; José Duca; Lorenzo Corti; Michele Pallaoro; Alfredo Pezzicoli; Anette Karle; Fabio Rigat; Rino Rappuoli; Vas Narasimhan; Ilkka Julkunen; Arja Vuorela; Outi Vaarala; Hanna Nohynek; Franco Laghi Pasini; Emanuele Montomoli; Claudia Trombetta; Christopher M Adams; Jonathan Rothbard; Lawrence Steinman
Journal:  Sci Transl Med       Date:  2015-07-01       Impact factor: 17.956

4.  Complement-dependent lysis of influenza a virus-infected cells by broadly cross-reactive human monoclonal antibodies.

Authors:  Masanori Terajima; John Cruz; Mary Dawn T Co; Jane-Hwei Lee; Kaval Kaur; Jens Wrammert; Patrick C Wilson; Francis A Ennis
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

5.  Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies.

Authors:  Sinthujan Jegaskanda; Emma R Job; Marit Kramski; Karen Laurie; Gamze Isitman; Robert de Rose; Wendy R Winnall; Ivan Stratov; Andrew G Brooks; Patrick C Reading; Stephen J Kent
Journal:  J Immunol       Date:  2013-01-14       Impact factor: 5.422

6.  Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells.

Authors:  G Hashimoto; P F Wright; D T Karzon
Journal:  J Infect Dis       Date:  1983-11       Impact factor: 5.226

7.  Ability of human cord blood lymphocytes to mediate antibody-dependent cellular cytotoxicity against influenza virus-infected cells.

Authors:  G Hashimoto; P F Wright; D T Karzon
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

8.  Expression of influenza A virus internal antigens on the surface of infected P815 cells.

Authors:  J W Yewdell; E Frank; W Gerhard
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

9.  H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial.

Authors:  Larisa Rudenko; Irina Isakova-Sivak; Anatoly Naykhin; Irina Kiseleva; Marina Stukova; Mariana Erofeeva; Daniil Korenkov; Victoria Matyushenko; Erin Sparrow; Marie-Paule Kieny
Journal:  Lancet Infect Dis       Date:  2015-12-08       Impact factor: 25.071

10.  Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9).

Authors:  Mahdee Sobhanie; Yumiko Matsuoka; Sinthujan Jegaskanda; Theresa Fitzgerald; Raburn Mallory; Zhongying Chen; Catherine Luke; John Treanor; Kanta Subbarao
Journal:  J Infect Dis       Date:  2015-12-09       Impact factor: 5.226

View more
  34 in total

1.  Heterologous viral protein interactions within licensed seasonal influenza virus vaccines.

Authors:  Marina Koroleva; Frances Batarse; Savannah Moritzky; Carole Henry; Francisco Chaves; Patrick Wilson; Florian Krammer; Katherine Richards; Andrea J Sant
Journal:  NPJ Vaccines       Date:  2020-01-10       Impact factor: 7.344

Review 2.  Inactivated influenza virus vaccines: the future of TIV and QIV.

Authors:  Michael Schotsaert; Adolfo García-Sastre
Journal:  Curr Opin Virol       Date:  2017-05-12       Impact factor: 7.090

Review 3.  Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design.

Authors:  Sinthujan Jegaskanda; Hillary A Vanderven; Adam K Wheatley; Stephen J Kent
Journal:  Hum Vaccin Immunother       Date:  2017-03-23       Impact factor: 3.452

4.  Protein Vaccination Directs the CD4+ T Cell Response toward Shared Protective Epitopes That Can Be Recalled after Influenza Virus Infection.

Authors:  Ajitanuj Rattan; Katherine A Richards; Zackery A G Knowlden; Andrea J Sant
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

5.  Fc functional antibodies in humans with severe H7N9 and seasonal influenza.

Authors:  Hillary A Vanderven; Lu Liu; Fernanda Ana-Sosa-Batiz; Thi Ho Nguyen; Yanmin Wan; Bruce Wines; P Mark Hogarth; Danielle Tilmanis; Arnold Reynaldi; Matthew S Parsons; Aeron C Hurt; Miles P Davenport; Tom Kotsimbos; Allen C Cheng; Katherine Kedzierska; Xiaoyan Zhang; Jianqing Xu; Stephen J Kent
Journal:  JCI Insight       Date:  2017-07-06

6.  Anti-Influenza Hyperimmune Immunoglobulin Enhances Fc-Functional Antibody Immunity During Human Influenza Infection.

Authors:  Hillary A Vanderven; Kathleen Wragg; Fernanda Ana-Sosa-Batiz; Anne B Kristensen; Sinthujan Jegaskanda; Adam K Wheatley; Deborah Wentworth; Bruce D Wines; P Mark Hogarth; Steve Rockman; Stephen J Kent
Journal:  J Infect Dis       Date:  2018-09-22       Impact factor: 5.226

Review 7.  The human antibody response to influenza A virus infection and vaccination.

Authors:  Florian Krammer
Journal:  Nat Rev Immunol       Date:  2019-06       Impact factor: 53.106

8.  Development and optimization of a Zika virus antibody-dependent cell-mediated cytotoxicity (ADCC) assay.

Authors:  Xuemin Chen; Larry J Anderson; Christina A Rostad; Lingmei Ding; Lilin Lai; Mark Mulligan; Nadine Rouphael; Muktha S Natrajan; Courtney McCracken; Evan J Anderson
Journal:  J Immunol Methods       Date:  2020-10-16       Impact factor: 2.303

9.  Influenza vaccination in the elderly boosts antibodies against conserved viral proteins and egg-produced glycans.

Authors:  Jiwon Jung; Sophia T Mundle; Irina V Ustyugova; Andrew P Horton; Daniel R Boutz; Svetlana Pougatcheva; Ponraj Prabakaran; Jonathan R McDaniel; Gregory R King; Daechan Park; Maria D Person; Congxi Ye; Bing Tan; Yuri Tanno; Jin Eyun Kim; Nicholas C Curtis; Joshua DiNapoli; Simon Delagrave; Ted M Ross; Gregory C Ippolito; Harry Kleanthous; Jiwon Lee; George Georgiou
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 14.808

Review 10.  B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat.

Authors:  Jenna J Guthmiller; Henry A Utset; Patrick C Wilson
Journal:  Viruses       Date:  2021-05-22       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.